|
| CNVs in neurodevelopmental disorders |
|
https://doi.org/10.18632/oncotarget.4853
Chun-Ting Lee, William J. Freed, and Deborah C. Mash
|
| 18238-18239 |
|
| USP8 mutation in Cushing’s disease |
|
https://doi.org/10.18632/oncotarget.4856
Chuanxin Huang, Yongyong Shi, and Yao Zhao
|
| 18240-18241 |
|
| Hyperactivated PI3Kδ in immunodeficiency |
|
https://doi.org/10.18632/oncotarget.4884
Lucie Heurtier, Marie-Céline Deau, and Sven Kracker
|
| 18242-18243 |
|
| Targeting interleukin17 receptors |
|
https://doi.org/10.18632/oncotarget.4892
Wen-Hwa Lee, Heng-Hsiung Wu, and Chun-Kai Huang
|
| 18244-18245 |
|
| PlGF immune system and hypertension |
|
https://doi.org/10.18632/oncotarget.4914
Daniela Carnevale, and Giuseppe Lembo
|
| 18246-18247 |
|
| Plasticity of coral physiology under ocean acidification |
|
https://doi.org/10.18632/oncotarget.4983
Alexander Ashley Venn, Eric Tambutté, and Sylvie Tambutté
|
| 18248-18249 |
|
| Mastocytosis: a mutated KIT receptor induced myeloproliferative disorder |
|
https://doi.org/10.18632/oncotarget.4213
Anindya Chatterjee, Joydeep Ghosh, and Reuben Kapur
|
| 18250-18264 |
|
| Long noncoding RNAs and neuroblastoma |
|
https://doi.org/10.18632/oncotarget.4251
Gaurav Kumar Pandey, and Chandrasekhar Kanduri
|
| 18265-18275 |
|
| The joining of the Hsp90 and Hsp70 chaperone cycles yields transient interactions and stable intermediates: insights from mass spectrometry |
|
https://doi.org/10.18632/oncotarget.4954
Carla Schmidt, Victoria Beilsten-Edmands, and Carol V. Robinson
|
| 18276-18281 |
|
| Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastomaendothelial cell interactions |
|
https://doi.org/10.18632/oncotarget.4957
Rajarshi Sengupta, Amy Barone, Jayne Marasa, Sara Taylor, Erin Jackson, Nicole M. Warrington, Shyam Rao, Albert H. Kim, Jeffrey R. Leonard, David Piwnica-Worms, and Joshua B. Rubin
|
| 18282-18292 |
|
| Exercisemimetic AICAR transiently benefits brain function |
|
https://doi.org/10.18632/oncotarget.4715
Davide Guerrieri, and Henriette van Praag
|
| 18293-18313 |
|
| The effects of graded levels of calorie restriction: III Impact of short term calorie and protein restriction on mean daily body temperature and torpor use in the C57BL/6 mouse |
|
https://doi.org/10.18632/oncotarget.4506
Sharon E. Mitchell, Camille Delville, Penelope Konstantopedos, Davina Derous, Cara L. Green, Luonan Chen, Jing-Dong J. Han, Yingchun Wang, Daniel E.L. Promislow, Alex Douglas, David Lusseau, and John R. Speakman
|
| 18314-18337 |
|
| Class 3 semaphorins expression and association with innervation and angiogenesis within the degenerate human intervertebral disc |
|
https://doi.org/10.18632/oncotarget.4274
Abbie L.A. Binch, Ashley A. Cole, Lee M. Breakwell, Anthony L.R. Michael, Neil Chiverton, Laura B. Creemers, Alison K. Cross, and Christine L. Le Maitre
|
| 18338-18354 |
|
| Human saliva as route of interhuman infection for mouse mammary tumor virus |
|
https://doi.org/10.18632/oncotarget.4567
Chiara Maria Mazzanti, Francesca Lessi, Ivana Armogida, Katia Zavaglia, Sara Franceschi, Mohammad A.L. Hamad, Manuela Roncella, Matteo Ghilli, Antonio Boldrini, Giovanni Fanelli, Ivo Marchetti, Cristian Scatena, Jacob Hochman, Antonio Giuseppe Naccarato, and Generoso Bevilacqua
|
| 18355-18363 |
|
| Redox process is crucial for inhibitory properties of aurintricarboxylic acid against activity of YopH: virulence factor of Yersinia pestis |
|
https://doi.org/10.18632/oncotarget.4625
Kuban-Jankowska Alicja, Sahu Kamlesh K, Niedzialkowski Pawel, Gorska Magdalena, Tuszynski Jack A, Ossowski Tadeusz, and Wozniak Michal
|
| 18364-18373 |
|
| MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large Bcell lymphoma |
|
https://doi.org/10.18632/oncotarget.4073
Ting-Xun Lu, Lei Fan, Li Wang, Jia-Zhu Wu, Kou-Rong Miao, Jin-Hua Liang, Qi-Xing Gong, Zhen Wang, Ken H. Young, Wei Xu, Zhi-Hong Zhang, and Jian-Yong Li
|
| 18374-18388 |
|
| MiR101 targets DUSP1 to regulate the TGFβ secretion in sorafenib inhibits macrophageinduced growth of hepatocarcinoma |
|
https://doi.org/10.18632/oncotarget.4089
Xufu Wei, Chengyong Tang, Xiuxian Lu, Rui Liu, Mi Zhou, Diao He, Daofeng Zheng, Chao Sun, and Zhongjun Wu
|
| 18389-18405 |
|
| AGPAT9 suppresses cell growth invasion and metastasis by counteracting acidic tumor microenvironment through KLF4/LASS2/VATPase signaling pathway in breast cancer |
|
https://doi.org/10.18632/oncotarget.4074
Shao-hua Fan, Yan-yan Wang, Zhi-yong Wu, Zi-feng Zhang, Jun Lu, Meng-qiu Li, Qun Shan, Dong-mei Wu, Chun-hui Sun, Bin Hu, and Yuan-lin Zheng
|
| 18406-18417 |
|
| Ebselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell lines |
|
https://doi.org/10.18632/oncotarget.4099
Paul D. Hanavan, Chad R. Borges, Benjamin A. Katchman, Douglas O. Faigel, Thai H. Ho, Chen-Ting Ma, Eduard A. Sergienko, Nathalie Meurice, Joachim L. Petit, and Douglas F. Lake
|
| 18418-18428 |
|
| miR29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2 |
|
https://doi.org/10.18632/oncotarget.4384
Hyun Joo Chung, Young Eun Choi, Eun Sook Kim, Young-Hoon Han, Myung-Jin Park, and In Hwa Bae
|
| 18429-18444 |
|
| YM155 a survivin suppressant triggers PARPdependent cell death parthanatos and inhibits esophageal squamouscell carcinoma xenografts in mice |
|
https://doi.org/10.18632/oncotarget.4315
Nan Zhao, Yousheng Mao, Gaijing Han, Qiang Ju, Lanping Zhou, Fang Liu, Yang Xu, and Xiaohang Zhao
|
| 18445-18459 |
|
| Prognostic significance of the TREK1 K2P potassium channels in prostate cancer |
|
https://doi.org/10.18632/oncotarget.3782
Gui-Ming Zhang, Fang-Ning Wan, Xiao-Jian Qin, Da-Long Cao, Hai-Liang Zhang, Yao Zhu, Bo Dai, Guo-Hai Shi, and Ding-Wei Ye
|
| 18460-18468 |
|
| PP2A inhibitors arrest G2/M transition through JNK/Sp1 dependent downregulation of CDK1 and autophagydependent upregulation of p21 |
|
https://doi.org/10.18632/oncotarget.4063
Fei-Ran Gong, Meng-Yao Wu, Meng Shen, Qiaoming Zhi, Ze-Kuan Xu, Rong Wang, Wen-Jie Wang, Yang Zong, Zeng-Liang Li, Yadi Wu, Binhua P. Zhou, Kai Chen, Min Tao, and Wei Li
|
| 18469-18483 |
|
| Factors involved in CLL pathogenesis and cell survival are disrupted by differentiation of CLL Bcells into antibodysecreting cells |
|
https://doi.org/10.18632/oncotarget.3941
Hussein Ghamlouch, Walaa Darwiche, Ahmed Hodroge, Hakim Ouled-Haddou, Sébastien Dupont, Amrathlal Rabbind Singh, Caroline Guignant, Stéphanie Trudel, Bruno Royer, Brigitte Gubler, and Jean-Pierre Marolleau
|
| 18484-18503 |
|
| Liposome encapsulated curcumindifluorinated CDF inhibits the growth of cisplatin resistant head and neck cancer stem cells |
|
https://doi.org/10.18632/oncotarget.4181
Saroj K. Basak, Alborz Zinabadi, Arthur W. Wu, Natarajan Venkatesan, Victor M. Duarte, James J. Kang, Clifton L. Dalgard, Meera Srivastava, Fazlul H. Sarkar, Marilene B. Wang, and Eri S. Srivatsan
|
| 18504-18517 |
|
| Chronic chemotherapeutic stress promotes evolution of stemness and WNT/betacatenin signaling in colorectal cancer cells: implications for clinical use of WNTsignaling inhibitors |
|
https://doi.org/10.18632/oncotarget.3934
Meriam Ayadi, Anaïs Bouygues, Djamila Ouaret, Nathalie Ferrand, Salem Chouaib, Jean-Paul Thiery, Christian Muchardt, Michèle Sabbah, and Annette K. Larsen
|
| 18518-18533 |
|
| C/EBPαp30 protein induces expression of the oncogenic long noncoding RNA UCA1 in acute myeloid leukemia |
|
https://doi.org/10.18632/oncotarget.4069
James M. Hughes, Ivano Legnini, Beatrice Salvatori, Silvia Masciarelli, Marcella Marchioni, Francesco Fazi, Mariangela Morlando, Irene Bozzoni, and Alessandro Fatica
|
| 18534-18544 |
|
| Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models |
|
https://doi.org/10.18632/oncotarget.4186
Martina D’Aronzo, Manlio Vinciguerra, Tommaso Mazza, Concetta Panebianco, Chiara Saracino, Stephen P. Pereira, Paolo Graziano, and Valerio Pazienza
|
| 18545-18557 |
|
| Ataxiatelangiectasia mutated ATM silencing promotes neuroblastoma progression through a MYCN independent mechanism |
|
https://doi.org/10.18632/oncotarget.4061
Stefano J. Mandriota, Linda J. Valentijn, Laurence Lesne, David R. Betts, Denis Marino, Mary Boudal-Khoshbeen, Wendy B. London, Anne-Laure Rougemont, Edward F. Attiyeh, John M. Maris, Michael D. Hogarty, Jan Koster, Jan J. Molenaar, Rogier Versteeg, Marc Ansari, and Fabienne Gumy-Pause
|
| 18558-18576 |
|
| Drosophila homologue of Diaphanous 1 DIAPH1 controls the metastatic potential of colon cancer cells by regulating microtubuledependent adhesion |
|
https://doi.org/10.18632/oncotarget.4094
Yuan-Na Lin, Ridhirama Bhuwania, Kira Gromova, Antonio Virgilio Failla, Tobias Lange, Kristoffer Riecken, Stefan Linder, Matthias Kneussel, Jakob R. Izbicki, and Sabine Windhorst
|
| 18577-18589 |
|
| Anticancer activity of MPT0G157 a derivative of indolylbenzenesulfonamide inhibits tumor growth and angiogenesis |
|
https://doi.org/10.18632/oncotarget.4068
Yen-Chia Huang, Fang-I Huang, Samir Mehndiratta, Ssu-Chia Lai, Jing-Ping Liou, and Chia-Ron Yang
|
| 18590-18601 |
|
| DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.4329
Chia-Yi Su, Tsung-Chieh Lin, Yuan-Feng Lin, Ming-Huang Chen, Chien-Hsin Lee, Hsuan-Yao Wang, Yu-Chieh Lee, Yu-Peng Liu, Chi-Long Chen, and Michael Hsiao
|
| 18602-18612 |
|
| MicroRNA451: epithelialmesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma |
|
https://doi.org/10.18632/oncotarget.4317
Jia-Yuan Huang, Kai Zhang, Dong-Qin Chen, Jing Chen, Bing Feng, Haizhu Song, Yitian Chen, Ziman Zhu, Lei Lu, Wei De, Rui Wang, and Long-Bang Chen
|
| 18613-18630 |
|
| Serum miR26a as a diagnostic and prognostic biomarker in cholangiocarcinoma |
|
https://doi.org/10.18632/oncotarget.4072
Li-Juan Wang, Kai-Liang Zhang, Ning Zhang, Xiang-Wei Ma, Su-Wen Yan, Dong-Hua Cao, and Sheng-Jia Shi
|
| 18631-18640 |
|
| Survival of patients with structurallygrouped TP53 mutations in ovarian and breast cancers |
|
https://doi.org/10.18632/oncotarget.4080
Brandon-Luke L. Seagle, Kevin H. Eng, Monica Dandapani, Judy Y. Yeh, Kunle Odunsi, and Shohreh Shahabi
|
| 18641-18652 |
|
| EpsteinBarr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival |
|
https://doi.org/10.18632/oncotarget.4418
Carlo Visco, Erika Falisi, Ken H. Young, Michela Pascarella, Omar Perbellini, Giuseppe Carli, Elisabetta Novella, Davide Rossi, Ilaria Giaretta, Chiara Cavallini, Maria Teresa Scupoli, Anita De Rossi, Emanuele Stefano Giovanni D’Amore, Mario Rassu, Gianluca Gaidano, Giovanni Pizzolo, Achille Ambrosetti, and Francesco Rodeghiero
|
| 18653-18663 |
|
| The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients |
|
https://doi.org/10.18632/oncotarget.4330
Sang Yun Ha, Insuk Sohn, Soo Hyun Hwang, Jung Wook Yang, and Cheol-Keun Park
|
| 18664-18673 |
|
| High EGFR and low pAkt expression is associated with better outcome after nimotuzumabcontaining treatment in esophageal cancer patients: preliminary clinical result and testable hypothesis |
|
https://doi.org/10.18632/oncotarget.4367
Chun-yu Wang, Jia-ying Deng, Xu-wei Cai, Xiao-long Fu, Yuan Li, Xiao-yan Zhou, Xiang-hua Wu, Xi-chun Hu, Min Fan, Jia-qing Xiang, Ya-wei Zhang, Hai-quan Chen, Rolando Perez, Guo-liang Jiang, and Kuai-le Zhao
|
| 18674-18682 |
|
| Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage IIIII HER2positive breast cancer patients: a phase 2 openlabel multicenter randomized trial |
|
https://doi.org/10.18632/oncotarget.4337
Liang Huang, Sheng Chen, Wentao Yang, Binghe Xu, Tao Huang, Hongjian Yang, Hong Zheng, Yongsheng Wang, Erwei Song, Jin Zhang, Shude Cui, Da Pang, Lili Tang, Yutao Lei, Cuizhi Geng, and Zhiming Shao
|
| 18683-18692 |
|
| A firstinhuman study of AMG 208 an oral MET inhibitor in adult patients with advanced solid tumors |
|
https://doi.org/10.18632/oncotarget.4472
David S. Hong, Peter Rosen, A. Craig Lockhart, Siqing Fu, Filip Janku, Razelle Kurzrock, Rabia Khan, Benny Amore, Isaac Caudillo, Hongjie Deng, Yuying C. Hwang, Robert Loberg, Gataree Ngarmchamnanrith, Darrin M. Beaupre, and Peter Lee
|
| 18693-18706 |
|
| Longterm results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.4531
Lai-ping Zhong, Chen-ping Zhang, Guo-xin Ren, Wei Guo, William N. William Jr, Christopher S. Hong, Jian Sun, Han-guang Zhu, Wen-yong Tu, Jiang Li, Yi-li Cai, Qiu-ming Yin, Li-zhen Wang, Zhong-he Wang, Yong-jie Hu, Tong Ji, Wen-jun Yang, Wei-min Ye, Jun Li, Yue He, Yan-an Wang, Li-qun Xu, Zhengping Zhuang, J. Jack Lee, Jeffrey N. Myers, and Zhi-yuan Zhang
|
| 18707-18714 |
|
| Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and metaanalysis |
|
https://doi.org/10.18632/oncotarget.4134
Xingshun Qi, Diya Wang, Chunping Su, Hongyu Li, and Xiaozhong Guo
|
| 18715-18733 |
